MYD88 and ovarian carcinoma: The signaling cascade involving TLR4 and MyD88 is understood to promote the development and spread of breast cancer [20], with its suppression being recognized as a promising treatment strategy for hepatocellular carcinoma [21] and epithelial ovarian cancer [22].